{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:26Z","timestamp":1793388446056,"version":"4.5.0"},"reference-count":251,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neuroimmunology is reshaping the understanding of the central nervous system (CNS), revealing it as an active immune organ rather than an isolated structure. This review delves into the unprecedented discoveries transforming the field, including the emerging roles of microglia, astrocytes, and the blood\u2013brain barrier (BBB) in orchestrating neuroimmune dynamics. Highlighting their dual roles in both repair and disease progression, we uncover how these elements contribute to the intricate pathophysiology of neurodegenerative diseases, cerebrovascular conditions, and CNS tumors. Novel insights into microglial priming, astrocytic cytokine networks, and meningeal lymphatics challenge the conventional paradigms of immune privilege, offering fresh perspectives on disease mechanisms. This work introduces groundbreaking therapeutic innovations, from precision immunotherapies to the controlled modulation of the BBB using nanotechnology and focused ultrasound. Moreover, we explore the fusion of immune modulation with neuromodulatory technologies, underscoring new frontiers for personalized medicine in previously intractable diseases. By synthesizing these advancements, we propose a transformative framework that integrates cutting-edge research with clinical translation, charting a bold path toward redefining CNS disease management in the era of precision neuroimmunology.<\/jats:p>","DOI":"10.3390\/ijms252413614","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:04:14Z","timestamp":1734595454000},"page":"13614","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders"],"prefix":"10.3390","volume":"25","author":[{"given":"Corneliu","family":"Toader","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calin Petru","family":"Tataru","sequence":"additional","affiliation":[{"name":"Department of Opthamology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Central Military Emergency Hospital \u201cDr. Carol Davila\u201d, 010825 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavian","family":"Munteanu","sequence":"additional","affiliation":[{"name":"Department of Anatomy, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan-Adrian","family":"Covache-Busuioc","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matei","family":"Serban","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru Vlad","family":"Ciurea","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Neurosurgery Department, Sanador Clinical Hospital, 010991 Bucharest, Romania"},{"name":"Medical Section, Romanian Academy, 010071 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaly","family":"Enyedi","sequence":"additional","affiliation":[{"name":"Department of Anatomy, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e20231942","DOI":"10.1084\/jem.20231942","article-title":"Hormonal basis of brain fog in cancer treatment","volume":"221","author":"Pan","year":"2024","journal-title":"J. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.neuron.2024.07.015","article-title":"Microglia are not necessary for maintenance of blood-brain barrier properties in health, but PLX5622 alters brain endothelial cholesterol metabolism","volume":"112","author":"Profaci","year":"2024","journal-title":"Neuron"},{"key":"ref_3","first-page":"308","article-title":"From Immune Sanctuary to Neurological Battlefield: The Role of Neuroimmune Cells","volume":"9","author":"Chakrabarti","year":"2024","journal-title":"Explor. Res. Hypothesis Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia Biology: One Century of Evolving Concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Seady, M., Schirmbeck, G., Taday, J., Fr\u00f3es, F.T., Ba\u00fa, J.V., Jantsch, J., Guedes, R.P., Gon\u00e7alves, C.-A., and Leite, M.C. (2025). Curcumin attenuates neuroinflammatory damage induced by LPS: Implications for the role of S100B. J. Nutr. Biochem., 135.","DOI":"10.1016\/j.jnutbio.2024.109768"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Daughters, R.S., Julian, L., Knock, E., and Willerth, S.M. (2024). Editorial: Next generation in vitro models of the human blood\u2013brain\/cerebrospinal fluid barrier. Front. Mol. Neurosci., 17.","DOI":"10.3389\/fnmol.2024.1371733"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wright, B., King, S., and Suphioglu, C. (2024). The Importance of Phosphoinositide 3-Kinase in Neuroinflammation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111638"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Natale, G., Limanaqi, F., Busceti, C.L., Mastroiacovo, F., Nicoletti, F., Puglisi-Allegra, S., and Fornai, F. (2021). Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.639140"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Toader, C., R\u0103doi, P.M., Aljboor, G.S.R., Glavan, L.-A., Covache-Busuioc, R.-A., Ilie, M.-M., and Ciurea, A.V. (2024). Coanda Effect Displayed in a Giant Intracranial Aneurysm. Brain Sci., 14.","DOI":"10.3390\/brainsci14090897"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/lrb.2018.0079","article-title":"Connections Between Amyloid Beta and the Meningeal Lymphatics As a Possible Route for Clearance and Therapeutics","volume":"18","author":"Dupont","year":"2020","journal-title":"Lymphat. Res. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bobotis, B.C., Halvorson, T., Carrier, M., and Tremblay, M.-\u00c8. (2024). Established and emerging techniques for the study of microglia: Visualization, depletion, and fate mapping. Front. Cell. Neurosci., 18.","DOI":"10.3389\/fncel.2024.1317125"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.4103\/NRR.NRR-D-24-00418","article-title":"Decline and fall of aging astrocytes: The human perspective","volume":"20","author":"Verkhratsky","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1038\/s41423-021-00751-3","article-title":"Microglia as hackers of the matrix: Sculpting synapses and the extracellular space","volume":"18","author":"Crapser","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/glia.23637","article-title":"Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders","volume":"67","author":"Bar","year":"2019","journal-title":"Glia"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Poon, M.M., Lorrain, K.I., Stebbins, K.J., Edu, G.C., Broadhead, A.R., Lorenzana, A.O., Paulson, B.E., Baccei, C.S., Roppe, J.R., and Schrader, T.O. (2024). Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61369-9"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.it.2024.08.008","article-title":"Emerging roles of astrocytes as immune effectors in the central nervous system","volume":"45","author":"Fisher","year":"2024","journal-title":"Trends Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/ATVBAHA.123.320367","article-title":"Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling","volume":"44","author":"Gongol","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Heng, A.H.S., Han, C.W., Abbott, C., McColl, S.R., and Comerford, I. (2022). Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.817473"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood\u2013brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holman","year":"2011","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbadis.2015.10.004","article-title":"Glial influences on BBB functions and molecular players in immune cell trafficking","volume":"1862","author":"Kebir","year":"2016","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Repici, A., Capra, A.P., Hasan, A., Bulzom\u00ec, M., Campolo, M., Paterniti, I., Esposito, E., and Ardizzone, A. (2024). Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson\u2019s Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084337"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/1871527317666180713111100","article-title":"Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges","volume":"17","author":"Khanahmad","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awy301","article-title":"Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis","volume":"142","author":"Hansen","year":"2019","journal-title":"Brain"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Eva, L., Ple\u0219, H., Covache-Busuioc, R.-A., Glavan, L.A., Bratu, B.-G., Bordeianu, A., Dumitrascu, D.-I., Corlatescu, A.D., and Ciurea, A.V. (2023). A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092489"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/brain\/awac019","article-title":"Intrinsic blood\u2013brain barrier dysfunction contributes to multiple sclerosis pathogenesis","volume":"145","author":"Nishihara","year":"2022","journal-title":"Brain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2153534","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2015.12.014","article-title":"Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis","volume":"771","author":"Yang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lu, W., Chen, Z., and Wen, J. (2024). Flavonoids and ischemic stroke-induced neuroinflammation: Focus on the glial cells. Biomed. Pharmacother., 170.","DOI":"10.1016\/j.biopha.2023.115847"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5853\/jos.2019.02236","article-title":"Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets","volume":"22","author":"Tschoe","year":"2020","journal-title":"J. Stroke"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acschemneuro.2c00196","article-title":"The Role of Neuroinflammatory Mediators in the Pathogenesis of Traumatic Brain Injury: A Narrative Review","volume":"13","author":"Erbakan","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume":"94","author":"Subhramanyam","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Saha, S., Buttari, B., Profumo, E., Tucci, P., and Saso, L. (2022). A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer\u2019s and Parkinson\u2019s Diseases. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.787258"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.02.008","article-title":"The relation between \u03b1-synuclein and microglia in Parkinson\u2019s disease: Recent developments","volume":"302","author":"Tentillier","year":"2015","journal-title":"Neuroscience"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2020.08.003","article-title":"Mechanisms of NLRP3 priming in inflammaging and age related diseases","volume":"55","author":"Gritsenko","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/imr.13317","article-title":"Epigenetic control of microglial immune responses","volume":"323","author":"Scholz","year":"2024","journal-title":"Immunol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Martins-Ferreira, R., Leal, B., Costa, P.P., and Ballestar, E. (2021). Microglial innate memory and epigenetic reprogramming in neurological disorders. Prog. Neurobiol., 200.","DOI":"10.1016\/j.pneurobio.2020.101971"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbi.2016.02.001","article-title":"Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions","volume":"54","author":"Crowley","year":"2016","journal-title":"Brain. Behav. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2014.10.020","article-title":"The therapeutic potential of interleukin-10 in neuroimmune diseases","volume":"96","author":"Kwilasz","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","article-title":"Immune modulation by curcumin: The role of interleukin-10","volume":"59","author":"Mollazadeh","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., and Lan, J. (2023). Microglia in Alzheimer\u2019s disease: Pathogenesis, mechanisms, and therapeutic potentials. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1201982"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Schiera, G., Di Liegro, C.M., Schir\u00f2, G., Sorbello, G., and Di Liegro, I. (2024). Involvement of Astrocytes in the Formation, Maintenance, and Function of the Blood\u2013Brain Barrier. Cells, 13.","DOI":"10.3390\/cells13020150"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Luo, Y., and Wang, Z. (2024). The Impact of Microglia on Neurodevelopment and Brain Function in Autism. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010210"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: Signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Cheray, M., and Joseph, B. (2018). Epigenetics Control Microglia Plasticity. Front. Cell. Neurosci., 12.","DOI":"10.3389\/fncel.2018.00243"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.it.2019.02.001","article-title":"Priming Microglia for Innate Immune Memory in the Brain","volume":"40","author":"Neher","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"102324","DOI":"10.1016\/j.arr.2024.102324","article-title":"Role of histone modifications in neurogenesis and neurodegenerative disease development","volume":"98","author":"Zhao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/1516-4446-2020-0987","article-title":"The role of the microbiota-gut-brain axis in neuropsychiatric disorders","volume":"43","author":"Generoso","year":"2020","journal-title":"Braz. J. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.12998\/wjcc.v10.i6.1754","article-title":"Gut-brain axis: Focus on gut metabolites short-chain fatty acids","volume":"10","author":"Guo","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Silva, Y.P., Bernardi, A., and Frozza, R.L. (2020). The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00025"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Fock, E., and Parnova, R. (2023). Mechanisms of Blood-Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids. Cells, 12.","DOI":"10.3390\/cells12040657"},{"key":"ref_54","first-page":"726","article-title":"Neuroimmune interactions and pain: Focus on glial-modulating targets","volume":"9","author":"Horvath","year":"2008","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11481-006-9015-5","article-title":"Microglia Biology in Health and Disease","volume":"1","author":"Garden","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s11481-013-9493-1","article-title":"Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype","volume":"8","author":"Kozela","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1471-4159.2010.06849.x","article-title":"Mending the broken brain: Neuroimmune interactions in neurogenesis","volume":"114","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"M\u0103run\u0163elu, I., Constantinescu, A.-E., Covache-Busuioc, R.-A., and Constantinescu, I. (2024). The Golgi Apparatus: A Key Player in Innate Immunity. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25074120"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Manenti, S., Orrico, M., Masciocchi, S., Mandelli, A., Finardi, A., and Furlan, R. (2022). PD-1\/PD-L Axis in Neuroinflammation: New Insights. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.877936"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Derakhshani, A., Asadzadeh, Z., Safarpour, H., Leone, P., Shadbad, M.A., Heydari, A., Baradaran, B., and Racanelli, V. (2021). Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFN\u03b2-1\u03b1, Glatiramer Acetate, and Dimethyl Fumarate Drugs. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080721"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Feghali, J., and Jackson, C.M. (2024). Therapeutic implications for the PD-1 axis in cerebrovascular injury. Neurotherapeutics, e00459.","DOI":"10.1016\/j.neurot.2024.e00459"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12974-023-02917-4","article-title":"Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1","volume":"20","author":"Smith","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2147\/JIR.S316439","article-title":"High Inflammatory Tendency Induced by Malignant Stimulation Through Imbalance of CD28 and CTLA-4\/PD-1 Contributes to Dopamine Neuron Injury","volume":"14","author":"Dong","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrneurol.2017.144","article-title":"Inflammatory CNS disease caused by immune checkpoint inhibitors: Status and perspectives","volume":"13","author":"Yshii","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11064-024-04121-z","article-title":"Effect of CTLA-4 Inhibition on Inflammation and Apoptosis After Spinal Cord Injury","volume":"49","author":"Mao","year":"2024","journal-title":"Neurochem. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bajracharya, R., Caruso, A.C., Vella, L.J., and Nisbet, R.M. (2021). Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13122014"},{"key":"ref_67","first-page":"100548","article-title":"Micro\/nanosystems for controllable drug delivery to the brain","volume":"5","author":"Tian","year":"2023","journal-title":"Innovation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1570159X18666200807143526","article-title":"Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems","volume":"19","author":"Patel","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e37533","DOI":"10.1016\/j.heliyon.2024.e37533","article-title":"A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer\u2019s disease","volume":"10","author":"Rouhi","year":"2024","journal-title":"Heliyon"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1039\/D3NA01125A","article-title":"Strategies for enhanced gene delivery to the central nervous system","volume":"6","author":"Gao","year":"2024","journal-title":"Nanoscale Adv."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1039\/D0BM00809E","article-title":"Nanomaterial Based Drug Delivery Systems for the Treatment of Neurodegenerative Diseases","volume":"8","author":"Asil","year":"2020","journal-title":"Biomater. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Tan, J.-K.Y., Sellers, D.L., Pham, B., Pun, S.H., and Horner, P.J. (2016). Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00108"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"121558","DOI":"10.1016\/j.lfs.2023.121558","article-title":"Interaction of tumor-associated microglia\/macrophages and cancer stem cells in glioma","volume":"320","author":"Zhu","year":"2023","journal-title":"Life Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.7150\/ijbs.83531","article-title":"The Evolution of Tumor Microenvironment in Gliomas and Its Implication for Target Therapy","volume":"19","author":"Hu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/1570159X20666220120120203","article-title":"Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas","volume":"21","author":"Anagnostakis","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.7150\/thno.73931","article-title":"Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke","volume":"12","author":"Hermann","year":"2022","journal-title":"Theranostics"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Xia, X., Wang, Y., Huang, Y., Zhang, H., Lu, H., and Zheng, J.C. (2019). Exosomal miRNAs in central nervous system diseases: Biomarkers, pathological mediators, protective factors and therapeutic agents. Prog. Neurobiol., 183.","DOI":"10.1016\/j.pneurobio.2019.101694"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Singh, G., Mehra, A., Arora, S., Gugulothu, D., Vora, L.K., Prasad, R., and Khatri, D.K. (2024). Exosome-mediated delivery and regulation in neurological disease progression. Int. J. Biol. Macromol., 264.","DOI":"10.1016\/j.ijbiomac.2024.130728"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/neuonc\/noaa029","article-title":"The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction","volume":"22","author":"Himes","year":"2020","journal-title":"Neuro-Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ye, L., Zhu, Z., Chen, X., Zhang, H., Huang, J., Gu, S., and Zhao, X. (2021). The Importance of Exosomal PD-L1 in Cancer Progression and Its Potential as a Therapeutic Target. Cells, 10.","DOI":"10.3390\/cells10113247"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Akbar, S., Raza, A., Mohsin, R., Kanbour, A., Qadri, S., Parray, A., Zar Gul, A.R., Philip, A., Vijayakumar, S., and Merhi, M. (2023). Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1\/PD-L1 therapy in non-small cell lung cancer patients. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1097117"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Franson, A., McClellan, B.L., Varela, M.L., Comba, A., Syed, M.F., Banerjee, K., Zhu, Z., Gonzalez, N., Candolfi, M., and Lowenstein, P. (2022). Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. Front. Med., 9.","DOI":"10.3389\/fmed.2022.966458"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, J., Nakahata, S., and Iha, H. (2024). Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137346"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Zhou, M., He, X., Mei, C., and Ou, C. (2023). Exosome derived from tumor-associated macrophages: Biogenesis, functions, and therapeutic implications in human cancers. Biomark. Res., 11.","DOI":"10.1186\/s40364-023-00538-w"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/21645515.2020.1782692","article-title":"PD-1\/PD-L1 immune checkpoint inhibitors in glioblastoma: Clinical studies, challenges and potential","volume":"17","author":"Yang","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s44194-024-00031-y","article-title":"Glioma-associated macrophages: Unraveling their dual role in the microenvironment and therapeutic implications","volume":"3","author":"Wang","year":"2024","journal-title":"Curr. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zhang, X., Zhao, L., Zhang, H., Zhang, Y., Ju, H., Wang, X., Ren, H., Zhu, X., and Dong, Y. (2022). The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1003651"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Alard, E., Butnariu, A.-B., Grillo, M., Kirkham, C., Zinovkin, D.A., Newnham, L., Macciochi, J., and Pranjol, M.Z.I. (2020). Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets. Cancers, 12.","DOI":"10.3390\/cancers12071826"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12957-021-02486-x","article-title":"Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses","volume":"20","author":"Roozbahani","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-020-01275-6","article-title":"Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wu, Y., Chen, X., Wang, L., Zhou, X., Liu, Y., Ji, D., Ren, P., Zhou, G.G., and Zhao, J. (2022). Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1\/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models. Viruses, 14.","DOI":"10.3390\/v14122796"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Noor, L., Upadhyay, A., and Joshi, V. (2024). Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin. Biology, 13.","DOI":"10.3390\/biology13100846"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drup.2019.04.002","article-title":"The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation","volume":"43","author":"Saleem","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Montoya, M., Gallus, M., Phyu, S., Haegelin, J., de Groot, J., and Okada, H. (2024). A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives. Cells, 13.","DOI":"10.3390\/cells13090726"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41582-024-00972-w","article-title":"CAR T cells offer hope in glioblastoma","volume":"20","author":"Fyfe","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"20420986211004745","DOI":"10.1177\/20420986211004745","article-title":"Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: A case-series and narrative review","volume":"12","author":"Thouvenin","year":"2021","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1007\/s00262-023-03498-0","article-title":"Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections","volume":"72","author":"Schmitt","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Malvaso, A., Giglio, P., Diamanti, L., Gastaldi, M., Vegezzi, E., Pace, A., Bini, P., and Marchioni, E. (2024). Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action. Brain Sci., 14.","DOI":"10.3390\/brainsci14080764"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Yang, L., Yu, H., Dong, S., Zhong, Y., and Hu, S. (2017). Recognizing and managing on toxicities in cancer immunotherapy. Tumor Biol., 39.","DOI":"10.1177\/1010428317694542"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s43188-024-00233-4","article-title":"Updates on the mechanisms of toxicities associated with monoclonal antibodies targeting growth factor signaling and immune cells in cancer","volume":"40","author":"Park","year":"2024","journal-title":"Toxicol. Res."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Hu, D., Zhang, W., Tang, J., Zhou, Z., Liu, X., and Shen, Y. (2021). Improving safety of cancer immunotherapy via delivery technology. Biomaterials, 265.","DOI":"10.1016\/j.biomaterials.2020.120407"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.acra.2023.04.004","article-title":"Imaging the Side Effects of CAR T Cell Therapy: A Primer for the Practicing Radiologist","volume":"30","author":"Huang","year":"2023","journal-title":"Acad. Radiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100006","DOI":"10.1016\/j.medidd.2019.100006","article-title":"NEUROPROTECTIVE IMMUNITY: Leukaemia Inhibitory Factor (LIF) as guardian of brain health","volume":"2","author":"Metcalfe","year":"2019","journal-title":"Med. Drug Discov."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Guo, Z., Ding, Y., Wang, M., Zhai, Q., Liu, J., and Du, Q. (2024). Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study. Pharmaceuticals, 17.","DOI":"10.3390\/ph17081025"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s13311-020-00844-3","article-title":"The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development","volume":"17","author":"Zera","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejphar.2018.06.028","article-title":"Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches","volume":"833","author":"Shekhar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1002\/mco2.651","article-title":"Endothelial dysfunction: Molecular mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11910-023-01282-2","article-title":"Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke","volume":"23","author":"Alsbrook","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"110332","DOI":"10.1016\/j.intimp.2023.110332","article-title":"Neuroinflammation and peripheral immunity: Focus on ischemic stroke","volume":"120","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Yamaoka-Tojo, M., and Tojo, T. (2024). Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination. Vaccines, 12.","DOI":"10.3390\/vaccines12030252"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Farrer, T.J., Moore, J.D., Chase, M., Gale, S.D., and Hedges, D.W. (2024). Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review. Pathogens, 13.","DOI":"10.3390\/pathogens13110974"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjpc\/zwae016","article-title":"Association of respiratory infections and the impact of vaccinations on cardiovascular diseases","volume":"31","author":"Rademacher","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13365-023-01144-0","article-title":"Stroke risk after varicella-zoster virus infection: A systematic review and meta-analysis","volume":"29","author":"Lu","year":"2023","journal-title":"J. Neurovirol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Zeng, J., Bao, T., Yang, K., Zhu, X., Wang, S., Xiang, W., Ge, A., Zeng, L., and Ge, J. (2023). The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1047550"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Li, J., Wang, Z., Li, J., Zhao, H., and Ma, Q. (2024). HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation. Transl. Stroke Res., 1\u201326.","DOI":"10.1007\/s12975-024-01258-5"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yu, H., Cai, Y., Zhong, A., Zhang, Y., Zhang, J., and Xu, S. (2021). The \u201cDialogue\u201d Between Central and Peripheral Immunity After Ischemic Stroke: Focus on Spleen. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.792522"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"113508","DOI":"10.1016\/j.expneurol.2020.113508","article-title":"CNS and peripheral immunity in cerebral ischemia: Partition and interaction","volume":"335","author":"Kim","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Granados-Martinez, C., Alfageme-Lopez, N., Navarro-Oviedo, M., Nieto-Vaquero, C., Cuartero, M.I., Diaz-Benito, B., Moro, M.A., Lizasoain, I., Hernandez-Jimenez, M., and Pradillo, J.M. (2024). Gut Microbiota, Bacterial Translocation, and Stroke: Current Knowledge and Future Directions. Biomedicines, 12.","DOI":"10.3390\/biomedicines12122781"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Xie, L., He, M., Ying, C., and Chu, H. (2024). Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk. Front. Mol. Neurosci., 17.","DOI":"10.3389\/fnmol.2024.1400808"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Han, S., Cai, L., Chen, P., and Kuang, W. (2023). A study of the correlation between stroke and gut microbiota over the last 20years: A bibliometric analysis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1191758"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/nf-2021-0030","article-title":"Brain\u2013body communication in stroke: Mens sana in corpore sano","volume":"28","author":"Winek","year":"2022","journal-title":"Neuroforum"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Tu\u0142owiecka, N., Kotl\u0119ga, D., Bohatyrewicz, A., and Szczuko, M. (2021). Could Lipoxins Represent a New Standard in Ischemic Stroke Treatment?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084207"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11064-023-03875-2","article-title":"Emerging Targets for Modulation of Immune Response and Inflammation in Stroke","volume":"48","author":"Thapa","year":"2023","journal-title":"Neurochem. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"577318","DOI":"10.1016\/j.jneuroim.2020.577318","article-title":"Neuroinflammation and fibrosis in stroke: The good, the bad and the ugly","volume":"346","author":"Amruta","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbi.2023.12.007","article-title":"Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke","volume":"116","author":"Kim","year":"2024","journal-title":"Brain. Behav. Immun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40264-018-0774-8","article-title":"Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer","volume":"42","author":"Baraibar","year":"2019","journal-title":"Drug Saf."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4252\/wjsc.v13.i8.1030","article-title":"Modulating poststroke inflammatory mechanisms: Novel aspects of mesenchymal stem cells, extracellular vesicles and microglia","volume":"13","author":"Xin","year":"2021","journal-title":"World J. Stem Cells"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Xiong, Y., Song, J., Huang, X., Pan, Z., Goldbrunner, R., Stavrinou, L., Lin, S., Hu, W., Zheng, F., and Stavrinou, P. (2022). Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.899887"},{"key":"ref_130","first-page":"1657","article-title":"Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: A promising treatment for acute central nervous system injury","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Barczuk, J., Siwecka, N., Lusa, W., Rozp\u0119dek-Kami\u0144ska, W., Kucharska, E., and Majsterek, I. (2022). Targeting NLRP3-Mediated Neuroinflammation in Alzheimer\u2019s Disease Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23168979"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"108595","DOI":"10.1016\/j.intimp.2022.108595","article-title":"MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes","volume":"106","author":"Bakhshi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e2400459","DOI":"10.1002\/ardp.202400459","article-title":"MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions","volume":"357","author":"Zheng","year":"2024","journal-title":"Arch. Pharm."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tins.2020.10.003","article-title":"Neuroprotective versus Neuroinflammatory Roles of Complement: From Development to Disease","volume":"44","author":"Kanmogne","year":"2021","journal-title":"Trends Neurosci."},{"key":"ref_135","first-page":"1","article-title":"Synaptic Pruning in Alzheimer\u2019s Disease: Role of the Complement System","volume":"20","author":"Brucato","year":"2020","journal-title":"Glob. J. Med. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"652","DOI":"10.14336\/AD.2019.0118","article-title":"Emerging Roles of Complement Protein C1q in Neurodegeneration","volume":"10","author":"Cho","year":"2019","journal-title":"Aging Dis."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Sun, Z., Zhang, X., So, K.-F., Jiang, W., and Chiu, K. (2024). Targeting Microglia in Alzheimer\u2019s Disease: Pathogenesis and Potential Therapeutic Strategies. Biomolecules, 14.","DOI":"10.3390\/biom14070833"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Ulland, T.K., and Colonna, M. (2018). TREM2-Dependent Effects on Microglia in Alzheimer\u2019s Disease. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00202"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","article-title":"Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"13","author":"Zhong","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","article-title":"Pathological \u03b1-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation","volume":"265","author":"Zhang","year":"2017","journal-title":"Toxicol. Lett."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5056\/jnm19044","article-title":"Parkinson\u2019s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation","volume":"25","author":"Dutta","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson\u2019s disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome\u2013gut\u2013brain axis in Parkinson disease\u2014From basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000334527","article-title":"Adeno-Associated Virus Type 2 Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Induces Neuroprotection and Neuroregeneration in a Ubiquitin-Proteasome System Impairment Animal Model of Parkinson\u2019s Disease","volume":"11","author":"Du","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2019.04.017","article-title":"B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients","volume":"332","author":"Gormley","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1177\/13524585211003301","article-title":"Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis","volume":"27","author":"Feng","year":"2021","journal-title":"Mult. Scler. J."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/13524585221147635","article-title":"Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis","volume":"29","author":"Abbadessa","year":"2023","journal-title":"Mult. Scler. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5316\/wjn.v5.i1.5","article-title":"Targeting remyelination treatment for multiple sclerosis","volume":"5","author":"Nadeem","year":"2015","journal-title":"World J. Neurol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Al Jaf, A.I.A., Peria, S., Fabiano, T., and Ragnini-Wilson, A. (2024). Remyelinating Drugs at a Crossroad: How to Improve Clinical Efficacy and Drug Screenings. Cells, 13.","DOI":"10.3390\/cells13161326"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s13311-017-0577-0","article-title":"Remyelinating Pharmacotherapies in Multiple Sclerosis","volume":"14","author":"Bove","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Zhao, X., and Jacob, C. (2023). Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076373"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40263-021-00798-w","article-title":"Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis","volume":"35","author":"Roy","year":"2021","journal-title":"CNS Drugs"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Chatzikonstantinou, S., Poulidou, V., Arnaoutoglou, M., Kazis, D., Heliopoulos, I., Grigoriadis, N., and Boziki, M. (2021). Signaling through the S1P\u2212S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment. Cells, 10.","DOI":"10.3390\/cells10113217"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e200330","DOI":"10.1212\/CPJ.0000000000200330","article-title":"Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy","volume":"14","author":"Wolf","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"102640","DOI":"10.1016\/j.msard.2020.102640","article-title":"Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial","volume":"47","author":"Bazi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00415-023-11690-6","article-title":"A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis","volume":"270","author":"Louapre","year":"2023","journal-title":"J. Neurol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"G\u0119bka-K\u0119pi\u0144ska, B., Adamczyk, B., G\u0119bka, D., Czuba, Z., Szczygie\u0142, J., and Adamczyk-Sowa, M. (2024). Cytokine Profiling in Cerebrospinal Fluid of Patients with Newly Diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS): Associations between Inflammatory Biomarkers and Disease Activity. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137399"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12974-024-03286-2","article-title":"Reimagining the meninges from a neuroimmune perspective: A boundary, but not peripheral","volume":"21","author":"Zhang","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41467-024-45656-7","article-title":"Non-invasive modulation of meningeal lymphatics ameliorates ageing and Alzheimer\u2019s disease-associated pathology and cognition in mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33160\/yam.2024.02.001","article-title":"Roles of Microglia in Neurodegenerative Diseases","volume":"67","author":"Nakaso","year":"2024","journal-title":"Yonago Acta Med."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Adamu, A., Li, S., Gao, F., and Xue, G. (2024). The role of neuroinflammation in neurodegenerative diseases: Current understanding and future therapeutic targets. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1347987"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","article-title":"Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells","volume":"620","author":"Sanmarco","year":"2023","journal-title":"Nature"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41586-022-05613-0","article-title":"Identification of astrocyte regulators by nucleic acid cytometry","volume":"614","author":"Clark","year":"2023","journal-title":"Nature"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"102229","DOI":"10.1016\/j.arr.2024.102229","article-title":"Evolving therapeutic interventions for the management and treatment of Alzheimer\u2019s disease","volume":"95","author":"Ahmad","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.apsb.2024.03.034","article-title":"Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer\u2019s disease","volume":"14","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s13311-020-00853-2","article-title":"Immunotherapies for Aging-Related Neurodegenerative Diseases\u2014Emerging Perspectives and New Targets","volume":"17","author":"Kwon","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"505","DOI":"10.34172\/apb.2021.058","article-title":"Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl\/6 Mouse Model of Multiple Sclerosis","volume":"11","author":"Gholamzad","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-022-02663-z","article-title":"Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/acn3.682","article-title":"Deep brain stimulation: Potential for neuroprotection","volume":"6","author":"McKinnon","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e00348","DOI":"10.1016\/j.neurot.2024.e00348","article-title":"Neuroscience fundamentals relevant to neuromodulation: Neurobiology of deep brain stimulation in Parkinson\u2019s disease","volume":"21","author":"Davidson","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Luo, Z., Xu, H., Samanta, S., Zhang, R., Luo, G., Wang, Y., Liu, L., Weng, X., He, J., and Liao, C. (2022). Long-Term Repeatable In Vivo Monitoring of Amyloid-\u03b2 Plaques and Vessels in Alzheimer\u2019s Disease Mouse Model with Combined TPEF\/CARS Microscopy. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112949"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Markowska, A., and Tarnacka, B. (2024). Molecular Changes in the Ischemic Brain as Non-Invasive Brain Stimulation Targets\u2014TMS and tDCS Mechanisms, Therapeutic Challenges, and Combination Therapies. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071560"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12991-024-00514-0","article-title":"Association between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: A systematic review","volume":"23","author":"Insan","year":"2024","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Toader, C., Tataru, C.P., Florian, I.-A., Covache-Busuioc, R.-A., Bratu, B.-G., Glavan, L.A., Bordeianu, A., Dumitrascu, D.-I., and Ciurea, A.V. (2023). Cognitive Crescendo: How Music Shapes the Brain\u2019s Structure and Function. Brain Sci., 13.","DOI":"10.3390\/brainsci13101390"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Muri, L., Oberh\u00e4nsli, S., Buri, M., Le, N.D., Grandgirard, D., Bruggmann, R., M\u00fcri, R.M., and Leib, S.L. (2020). Repetitive transcranial magnetic stimulation activates glial cells and inhibits neurogenesis after pneumococcal meningitis. PLoS ONE, 15.","DOI":"10.1101\/2020.04.24.059337"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Krsek, A., Ostojic, L., Zivalj, D., and Baticic, L. (2024). Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons\u2014A Comprehensive Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179695"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"100859","DOI":"10.1016\/j.bbih.2024.100859","article-title":"Vagus nerve stimulation: Novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity","volume":"42","author":"Brem","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"110863","DOI":"10.1016\/j.mehy.2022.110863","article-title":"Assessing the structural and functional changes in vagus nerve in multiple sclerosis","volume":"164","author":"Abdelnaby","year":"2022","journal-title":"Med. Hypotheses"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s13311-022-01283-y","article-title":"A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer\u2019s Disease Mice","volume":"19","author":"Rofo","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1080\/17425247.2023.2193390","article-title":"Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier","volume":"20","author":"Bao","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Hargarten, J.C., Ssebambulidde, K., Anjum, S.H., Vaughan, M.J., Xu, J., Song, B., Ganguly, A., Park, Y., Scott, T., and Hammoud, D.A. (2024). JAK\/STAT Signaling Predominates in Human and Murine Fungal Post-infectious Inflammatory Response Syndrome. medRxiv.","DOI":"10.1101\/2024.01.18.24301483"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"110988","DOI":"10.1016\/j.brainresbull.2024.110988","article-title":"SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options","volume":"213","author":"Yan","year":"2024","journal-title":"Brain Res. Bull."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1002\/mco2.254","article-title":"Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2","volume":"4","author":"Xue","year":"2023","journal-title":"MedComm"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Jensen, L.T., Attfield, K.E., Feldmann, M., and Fugger, L. (2023). Allosteric TYK2 inhibition: Redefining autoimmune disease therapy beyond JAK1-3 inhibitors. eBioMedicine, 97.","DOI":"10.1016\/j.ebiom.2023.104840"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Tong, B., Ba, Y., Li, Z., Yang, C., Su, K., Qi, H., Zhang, D., Liu, X., Wu, Y., and Chen, Y. (2024). Targeting dysregulated lipid metabolism for the treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease: Current advancements and future prospects. Neurobiol. Dis., 196.","DOI":"10.1016\/j.nbd.2024.106505"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Sharma, A., and Lee, H.-J. (2021). Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121914"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Fletcher, S.-M.P., Chisholm, A., Lavelle, M., Guthier, R., Zhang, Y., Power, C., Berbeco, R., and McDannold, N. (2024). A study combining microbubble-mediated focused ultrasound and radiation therapy in the healthy rat brain and a F98 glioma model. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-55442-6"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12964-024-01562-5","article-title":"The enhanced antitumor activity of bispecific antibody targeting PD-1\/PD-L1 signaling","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun. Signal. CCS"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e005583","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Zeng, J., Li, X., Sander, M., Zhang, H., Yan, G., and Lin, Y. (2021). Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.721830"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4103\/1673-5374.369096","article-title":"Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer\u2019s disease","volume":"18","author":"Unnisa","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_193","first-page":"1","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Fajardo-Serrano, A., Rico, A.J., Roda, E., Honrubia, A., Arrieta, S., Ariznabarreta, G., Chocarro, J., Lorenzo-Ramos, E., Pejenaute, A., and V\u00e1zquez, A. (2022). Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040746"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.18632\/aging.202501","article-title":"CRISPR\/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP\/PS1 mice","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: New hope for Alzheimer\u2019s disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.7150\/thno.83066","article-title":"New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)","volume":"13","author":"Palanisamy","year":"2023","journal-title":"Theranostics"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1515\/revneuro-2022-0102","article-title":"Current advances in stem cell therapy in the treatment of multiple sclerosis","volume":"34","author":"Baghbadorani","year":"2023","journal-title":"Rev. Neurosci."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Wu, L., Lu, J., Lan, T., Zhang, D., Xu, H., Kang, Z., Peng, F., and Wang, J. (2024). Stem cell therapies: A new era in the treatment of multiple sclerosis. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1389697"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Al-Onaizi, M., ElAli, A., and Alzaid, F. (2024). Editorial: Neuroinflammation, neurodegeneration and metabolic disease: From molecular mechanisms to therapeutic innovation. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1478550"},{"key":"ref_201","unstructured":"Silva, C.E., and Helena, J. (2024). Development of New Oligodendrocyte-Based Models to Identify Pharmacological Agents with Remyelinating Activity. [Ph.D. Thesis, Universit\u00e0 degli Studi di Milano]. Available online: https:\/\/tesidottorato.depositolegale.it\/handle\/20.500.14242\/85438."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez Rojo, N., Blanco Ben\u00edtez, M., Cava, R., Fuentes, J.M., Canales Cort\u00e9s, S., and Gonz\u00e1lez Polo, R.A. (2024). Convergence of Neuroinflammation, Microbiota, and Parkinson\u2019s Disease: Therapeutic Insights and Prospects. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111629"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3934\/Neuroscience.2024020","article-title":"Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson\u2019s disease","volume":"11","author":"Kumar","year":"2024","journal-title":"AIMS Neurosci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14728222.2022.2079492","article-title":"Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson\u2019s disease","volume":"26","author":"Yang","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Chen, B., Marquez-Nostra, B., Belitzky, E., Toyonaga, T., Tong, J., Huang, Y., and Cai, Z. (2022). PET Imaging in Animal Models of Alzheimer\u2019s Disease. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.872509"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1586\/ern.10.117","article-title":"Immunomodulatory drug treatment in multiple sclerosis","volume":"10","author":"Aharoni","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"527","DOI":"10.21037\/qims.2020.01.04","article-title":"MRI biomarkers of disease progression in multiple sclerosis: Old dog, new tricks?","volume":"10","author":"Barnett","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Rebiai, R., Givogri, M.I., Gowrishankar, S., Cologna, S.M., Alford, S.T., and Bongarzone, E.R. (2021). Synaptic Function and Dysfunction in Lysosomal Storage Diseases. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.619777"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Wattanapanitch, M., Chailangkarn, T., Miranda, H.C., and Muotri, A.R. (2023). Editorial: Advances in iPSC technology for disease modeling and therapeutic applications. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1261279"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Pascoal, T., Bellaver, B., Povala, G., Ferreira, P., Ferrari-Souza, J.P., Leffa, D., Lussier, F., Benedet, A., Ashton, N., and Triana-Baltzerz, G. (2023). Astrocyte reactivity influences the association of amyloid-\u03b2 and tau biomarkers in preclinical Alzheimer\u2019s disease. Res. Sq.","DOI":"10.21203\/rs.3.rs-2507179\/v1"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","article-title":"Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults","volume":"146","author":"Yu","year":"2023","journal-title":"Acta Neuropathol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","article-title":"Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis","volume":"81","author":"Cross","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","article-title":"The genetics of multiple sclerosis: An up-to-date review","volume":"248","author":"Gourraud","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1586\/14737175.7.9.1175","article-title":"Recent advances in genetic analysis of multiple sclerosis: Genetic associations and therapeutic implications","volume":"7","author":"Niino","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2019.04.013","article-title":"Updating Neuroimmune Targets in Central Nervous System Dysfunction","volume":"40","author":"Valente","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Rahman, M.M., Islam, M.R., Islam, M.T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M.B., Das, S., Rahaman, M.S., and Ahmed, M. (2022). Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives. Biology, 11.","DOI":"10.3390\/biology11010147"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Vicidomini, C., Fontanella, F., D\u2019Alessandro, T., and Roviello, G.N. (2024). A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases. Biomolecules, 14.","DOI":"10.3390\/biom14101330"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Silva-Sp\u00ednola, A., Baldeiras, I., Arrais, J.P., and Santana, I. (2022). The Road to Personalized Medicine in Alzheimer\u2019s Disease: The Use of Artificial Intelligence. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020315"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Salman, M.M., Al-Obaidi, Z., Kitchen, P., Loreto, A., Bill, R.M., and Wade-Martins, R. (2021). Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094688"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Di Lazzaro, G., Picca, A., Boldrini, S., Bove, F., Marzetti, E., Petracca, M., Piano, C., Bentivoglio, A.R., and Calabresi, P. (2024). Differential profiles of serum cytokines in Parkinson\u2019s disease according to disease duration. Neurobiol. Dis., 190.","DOI":"10.1016\/j.nbd.2023.106371"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Pant, T., Uche, N., Juric, M., Zielonka, J., and Bai, X. (2024). Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases. Redox Biol., 70.","DOI":"10.1016\/j.redox.2024.103077"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"175","DOI":"10.21037\/atm.2018.04.23","article-title":"Tau in neurodegenerative disease","volume":"6","author":"Gao","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_224","first-page":"152","article-title":"Non-Amyloid Approaches to Disease Modification for Alzheimer\u2019s Disease: An EU\/US CTAD Task Force Report","volume":"7","author":"Gauthier","year":"2020","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer\u2019s disease: The prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"122838","DOI":"10.1016\/j.lfs.2024.122838","article-title":"Repositioning of baricitinib for management of memory impairment in ovariectomized\/D-galactose treated rats: A potential role of JAK2\/STAT3-PI3K\/AKT\/mTOR signaling pathway","volume":"351","author":"Hindam","year":"2024","journal-title":"Life Sci."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/bph.15397","article-title":"Neurological risks and benefits of cytokine-based treatments in coronavirus disease 2019: From preclinical to clinical evidence","volume":"179","author":"Pignataro","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"577758","DOI":"10.1016\/j.jneuroim.2021.577758","article-title":"The involvement of JAK\/STAT signaling pathway in the treatment of Parkinson\u2019s disease","volume":"361","author":"Lashgari","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","article-title":"Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: A randomized, placebo-controlled, phase 2 clinical trial","volume":"27","author":"Harnett","year":"2021","journal-title":"Nat. Med."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.7150\/thno.50701","article-title":"PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity","volume":"11","author":"Rombaut","year":"2021","journal-title":"Theranostics"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics5010127","article-title":"From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)","volume":"5","author":"Angelova","year":"2013","journal-title":"Pharmaceutics"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5607\/en21039","article-title":"Conformation-specific Antibodies Targeting Aggregated Forms of \u03b1-synuclein Block the Propagation of Synucleinopathy","volume":"31","author":"Choi","year":"2022","journal-title":"Exp. Neurobiol."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Martinelli, A.H.S., Lopes, F.C., John, E.B.O., Carlini, C.R., and Ligabue-Braun, R. (2019). Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061322"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Monroy, G.R., Murguiondo P\u00e9rez, R., Weintraub Ben Zi\u00f3n, E., Vidal Alc\u00e1ntar-Garibay, O., Loza-L\u00f3pez, E.C., Tejerina Marion, E., Blancarte Hern\u00e1ndez, E., Navarro-Torres, L., and Ibarra, A. (2023). Immunization with Neural-Derived Peptides in Neurodegenerative Diseases: A Narrative Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030919"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"5341375","DOI":"10.34133\/2019\/5341375","article-title":"Promising Results from Alzheimer\u2019s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine","volume":"2019","author":"Marciani","year":"2019","journal-title":"Research"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/imt-2016-0019","article-title":"Tau-Based Therapeutics for Alzheimer\u2019s Disease: Active and Passive Immunotherapy","volume":"8","author":"Panza","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Mantile, F., and Prisco, A. (2020). Vaccination against \u03b2-Amyloid as a Strategy for the Prevention of Alzheimer\u2019s Disease. Biology, 9.","DOI":"10.3390\/biology9120425"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Rodger, A.T., ALNasser, M., and Carter, W.G. (2023). Are Therapies That Target \u03b1-Synuclein Effective at Halting Parkinson\u2019s Disease Progression? A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311022"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.26377","article-title":"Active immunization therapies for Parkinson\u2019s disease and multiple system atrophy","volume":"31","author":"Schneeberger","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"e135633","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17460441.2023.2160440","article-title":"Neuroinflammation, immune response and \u03b1-synuclein pathology: How animal models are helping us to connect dots","volume":"18","author":"Balzano","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Hanafy, A.S., Schoch, S., and Lamprecht, A. (2020). CRISPR\/Cas9 Delivery Potentials in Alzheimer\u2019s Disease Management: A Mini Review. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090801"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer\u2019s Disease\u2014A Narrative Review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol. Ther."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s44258-023-00004-0","article-title":"Non-viral approaches for gene therapy and therapeutic genome editing across the blood\u2013brain barrier","volume":"1","author":"Xie","year":"2023","journal-title":"Med-X"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2016.09.015","article-title":"Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys","volume":"110","author":"Garbayo","year":"2016","journal-title":"Biomaterials"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/mds.23793","article-title":"Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson\u2019s disease","volume":"26","author":"Garbayo","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Oehrn, C.R., Cernera, S., Hammer, L.H., Shcherbakova, M., Yao, J., Hahn, A., Wang, S., Ostrem, J.L., Little, S., and Starr, P.A. (2023). Personalized chronic adaptive deep brain stimulation outperforms conventional stimulation in Parkinson\u2019s disease. medRxiv.","DOI":"10.1101\/2023.08.03.23293450"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Merola, A., Singh, J., Reeves, K., Changizi, B., Goetz, S., Rossi, L., Pallavaram, S., Carcieri, S., Harel, N., and Shaikhouni, A. (2021). New Frontiers for Deep Brain Stimulation: Directionality, Sensing Technologies, Remote Programming, Robotic Stereotactic Assistance, Asleep Procedures, and Connectomics. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.694747"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"046042","DOI":"10.1088\/1741-2552\/ac86a2","article-title":"Automated deep brain stimulation programming with safety constraints for tremor suppression in patients with Parkinson\u2019s disease and essential tremor","volume":"19","author":"Sarikhani","year":"2022","journal-title":"J. Neural Eng."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/07388551.2021.1993126","article-title":"Neurodegenerative disorders management: State-of-art and prospects of nano-biotechnology","volume":"42","author":"Kumar","year":"2022","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Nayab, D.E., ud Din, F., Ali, H., Kausar, W.A., Urooj, S., Zafar, M., Khan, I., Shabbir, K., and Khan, G.M. (2023). Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: An up-to-date perspective. J. Nanobiotechnology, 21.","DOI":"10.1186\/s12951-023-02250-1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13614\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:39Z","timestamp":1760115339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":251,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252413614"],"URL":"https:\/\/doi.org\/10.3390\/ijms252413614","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}